| Bioactivity | Alrefimotide is a hTERT-derived immunogenic peptide. Alrefimotide has a sequence of ALFSVLNYERARRPGLLGASVLGLDDIHRA. Alrefimotide can be used in cancer immunotherapy research[1]. |
| Name | Alrefimotide |
| CAS | 1331848-79-3 |
| Sequence | Ala-Leu-Phe-Ser-Val-Leu-Asn-Tyr-Glu-Arg-Ala-Arg-Arg-Pro-Gly-Leu-Leu-Gly-Ala-Ser-Val-Leu-Gly-Leu-Asp-Asp-Ile-His-Arg-Ala |
| Shortening | ALFSVLNYERARRPGLLGASVLGLDDIHRA |
| Formula | C146H239N45O41 |
| Molar Mass | 3280.74 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Eishiro Mizukoshi, et al. Telomerase-Targeted Cancer Immunotherapy. Int J Mol Sci . 2019, 20, 8. |
Alrefimotide
CAS: 1331848-79-3 F: C146H239N45O41 W: 3280.74
Alrefimotide is a hTERT-derived immunogenic peptide. Alrefimotide has a sequence of ALFSVLNYERARRPGLLGASVLGLDDIHRA. Alre
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.